Search research articles
Contact Us
Filters
Showing results (101-110 of 509) with videos related to
Page
of 51
Sort By:
Seminars in Nephrology
|
July 1, 1996
Nephrotic syndrome in the elderly
J S Cameron
British Journal of Rheumatology
|
February 1, 1990
When a patient with known lupus nephritis has persistent proteinuria despite corticosteroids and immunosuppressive treatment can it be assumed that there is continuing disease activity or may it reflect irreparable glomerular damage? How can one be sure?
J S Cameron
Journal of the Royal College of Physicians of London
|
July 1, 1971
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs
J S Cameron
Journal of the Irish Medical Association
|
September 9, 1971
Immunodepressant drugs in the treatment of glomerulonephritis
J S Cameron
Comparative Biochemistry and Physiology. C: Comparative Pharmacology
|
January 1, 1979
Autonomic nervous tone and regulation of heart rate in the goldfish, Carassius auratus
J S Cameron
Nephron
|
January 1, 1981
Cardiovascular disease and the nephrotic syndrome: the other side of the coin
V Wass, J S Cameron
Seminars in Nephrology
|
March 1, 1985
Clinical and pathologic aspects of renal vasculitis
A Serra, J S Cameron
Lancet (London, England)
|
June 30, 1979
Platelet involvement in loin-pain/haematuria syndrome
A Parbtani, J S Cameron
Cardiovascular Research
|
June 1, 1994
Role of ATP sensitive potassium channels in long term adaptation to metabolic stress
J S Cameron, R Baghdady
Clinical and Experimental Immunology
|
March 1, 1979
The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit
P Trevillian, J S Cameron
Page
of 51
Search research articles
Search
Showing results (101-110 of 509) with videos related to
Sort By:
Page
of 51
Seminars in Nephrology
|
July 1, 1996
Nephrotic syndrome in the elderly
J S Cameron
British Journal of Rheumatology
|
February 1, 1990
When a patient with known lupus nephritis has persistent proteinuria despite corticosteroids and immunosuppressive treatment can it be assumed that there is continuing disease activity or may it reflect irreparable glomerular damage? How can one be sure?
J S Cameron
Journal of the Royal College of Physicians of London
|
July 1, 1971
Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs
J S Cameron
Journal of the Irish Medical Association
|
September 9, 1971
Immunodepressant drugs in the treatment of glomerulonephritis
J S Cameron
Comparative Biochemistry and Physiology. C: Comparative Pharmacology
|
January 1, 1979
Autonomic nervous tone and regulation of heart rate in the goldfish, Carassius auratus
J S Cameron
Nephron
|
January 1, 1981
Cardiovascular disease and the nephrotic syndrome: the other side of the coin
V Wass, J S Cameron
Seminars in Nephrology
|
March 1, 1985
Clinical and pathologic aspects of renal vasculitis
A Serra, J S Cameron
Lancet (London, England)
|
June 30, 1979
Platelet involvement in loin-pain/haematuria syndrome
A Parbtani, J S Cameron
Cardiovascular Research
|
June 1, 1994
Role of ATP sensitive potassium channels in long term adaptation to metabolic stress
J S Cameron, R Baghdady
Clinical and Experimental Immunology
|
March 1, 1979
The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit
P Trevillian, J S Cameron
Page
of 51